FYI: FDA habla español

Share this article:

The FDA's watchdogs are putting their language skills to use. Regulatory Focus reports that the regulator issued a Warning Letter to website owner Ramon Rosa for misbranding his products.

Rosa claimed his drugs could treat illnesses including cancer, ringworm, diabetes and arthritis, and the FDA says it has not approved these claims. What makes this Warning Letter different is that it is about materials written in Spanish.

RF notes that the majority of the FDA's promotional monitoring focuses on English language promos, but that it has the authority to review Spanish-language materials if they are published in Puerto Rico—which is where Rosa is based.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters